NCT02712970

Brief Summary

A staging system was defined based on morphological extent of disease (stage I to stage IV for primary disease, and stage R for recurrent disease). Specific surgical technique was used for each stage. Demographics, perioperative data, short-term and long-term outcomes were evaluated according to the disease stage.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
367

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2011

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 18, 2016

Completed
Last Updated

March 18, 2016

Status Verified

March 1, 2016

Enrollment Period

3.9 years

First QC Date

March 5, 2016

Last Update Submit

March 14, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Early wound complications

    Complications were classified as infection (superficial or deep), collection (seroma or hematoma), wound dehiscence (partial or complete), or anesthesia-related complications. complications will be reviewed from time of surgery to the end of healing. percentage of participants with any wound complication will be evaluated as patients with complication.

    up to 3 months

Secondary Outcomes (4)

  • Assessment of recurrence (recurrence is defined when symptoms of the disease recurred after an interval following complete wound healing.)

    3 years

  • Primary healing rate

    within 3 months

  • Hospital stay "The interval from the day of surgery to the day of discharge was recorded as the ''hospital stay.''

    during first week (one week)

  • Operative duration (''Operative duration'' is defined as the time between the initiation of the incision and the application of the last suture.)

    during surgery

Study Arms (5)

stage-I

Single pit in the midline, no lateral extension. Pit-picking technique will be performed.

Procedure: pit-picking technique

Stage-II

\>1 pits in the midline, no lateral extension. Pit-picking and Bascom cleft lift techniques will be performed.

Procedure: pit-picking techniqueProcedure: Bascom Cleft Lift

Stage-III

Midline pit/pits plus lateral extension in one direction. Bascom cleft lift technique will be performed.

Procedure: Bascom Cleft Lift

Stage-IV

Midline pit/pits plus lateral extension in both directions. Rhomboid excision with the Limberg Flap will be performed.

Procedure: Rhomboid excision with the Limberg Flap

Stage-R

Recurrent PSD following any type of treatment. Other flap techniques such as V-Y advancement flap, Z-Plasty will be performed.

Procedure: Bascom Cleft LiftProcedure: Rhomboid excision with the Limberg FlapProcedure: Other flap techniques

Interventions

midline pits were excised removing a minimal amount of tissue (with a margin of skin of \<1 mm). Incision of 1-2 cm in length was performed parallel to the most convenient side of the midline to be curetted of the chronic abscess cavity. All infected granulation tissue and hair were removed. After establishing hemostasis, the area of the excised midline pits was approximated by absorbable sutures.

Stage-IIstage-I

The upper end of the incision was made 1-2 cm lateral to the midline on the more affected side and this was continued vertically over a distance of 1-2 mm from the midline pits. The lower end was fashioned from the midline in a V-shape in order to prevent a dog-ear deformity. The skin on this side of the natal cleft was then elevated and excised. The skin on the opposite side was undermined to the distance required to allow primary closure of the defect away from the midline without tension. Sinus tissue and its extensions were excised. The incision was then closed subcuticularly by absorbable polyglecaprone (3-0), after which a few interrupted mattress polyglecaprone (3-0) buttress sutures were also inserted.

Stage-IIStage-IIIStage-R

The area to be excised was mapped on the skin in a rhomboid form, and the flap was designed. The skin incision was deepened to the postsacral fascia. The flap was fully mobilized and transposed medially to fill the defect without tension. The wound was closed in two layers: the subcutaneous tissue with absorbable (2/0 polyglactin) sutures and the skin with nonabsorbable (3/0 polypropylene) interrupted mattress suture

Stage-IVStage-R

Bascom Cleft lift as described above, Rhomboid excision with the Limberg Flap as described above, V-Y advancement flap, Z-Plasty

Stage-R

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients that were operated because of chronic symptomatic pilonidal sinus disease

You may qualify if:

  • Individuals with symptomatic pilonidal sinus disease.

You may not qualify if:

  • \<18 y
  • Pilonidal sinus disease which identified incidentally and which presented with acute abscesses were not included to the staging system.
  • Patients who were treated without the use of the suggested algorithm were excluded from the analysis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Guner A, Boz A, Ozkan OF, Ileli O, Kece C, Reis E. Limberg flap versus Bascom cleft lift techniques for sacrococcygeal pilonidal sinus: prospective, randomized trial. World J Surg. 2013 Sep;37(9):2074-80. doi: 10.1007/s00268-013-2111-9.

    PMID: 23732258BACKGROUND
  • Guner A, Ozkan OF, Kece C, Kesici S, Kucuktulu U. Modification of the Bascom cleft lift procedure for chronic pilonidal sinus: results in 141 patients. Colorectal Dis. 2013 Jul;15(7):e402-6. doi: 10.1111/codi.12243.

    PMID: 23581906BACKGROUND
  • Bascom J, Bascom T. Utility of the cleft lift procedure in refractory pilonidal disease. Am J Surg. 2007 May;193(5):606-9; discussion 609. doi: 10.1016/j.amjsurg.2007.01.008.

    PMID: 17434365BACKGROUND
  • Mentes O, Bagci M, Bilgin T, Ozgul O, Ozdemir M. Limberg flap procedure for pilonidal sinus disease: results of 353 patients. Langenbecks Arch Surg. 2008 Mar;393(2):185-9. doi: 10.1007/s00423-007-0227-9. Epub 2007 Sep 22.

    PMID: 17899165BACKGROUND
  • Can MF, Sevinc MM, Hancerliogullari O, Yilmaz M, Yagci G. Multicenter prospective randomized trial comparing modified Limberg flap transposition and Karydakis flap reconstruction in patients with sacrococcygeal pilonidal disease. Am J Surg. 2010 Sep;200(3):318-27. doi: 10.1016/j.amjsurg.2009.08.042. Epub 2010 Feb 1.

    PMID: 20122682BACKGROUND
  • Kement M, Oncel M, Kurt N, Kaptanoglu L. Sinus excision for the treatment of limited chronic pilonidal disease: results after a medium-term follow-up. Dis Colon Rectum. 2006 Nov;49(11):1758-62. doi: 10.1007/s10350-006-0676-1.

    PMID: 16990977BACKGROUND
  • Guner A, Cekic AB, Boz A, Turkyilmaz S, Kucuktulu U. A proposed staging system for chronic symptomatic pilonidal sinus disease and results in patients treated with stage-based approach. BMC Surg. 2016 Apr 16;16:18. doi: 10.1186/s12893-016-0134-5.

MeSH Terms

Conditions

Pilonidal Sinus

Condition Hierarchy (Ancestors)

CystsNeoplasms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

March 5, 2016

First Posted

March 18, 2016

Study Start

January 1, 2011

Primary Completion

December 1, 2014

Study Completion

June 1, 2015

Last Updated

March 18, 2016

Record last verified: 2016-03

Data Sharing

IPD Sharing
Will not share

because this is retrospective study.